109
Participants
Start Date
April 30, 2007
Primary Completion Date
March 31, 2011
Study Completion Date
March 31, 2011
entecavir
Tablets, Oral, 1 mg, once daily, up to 72 weeks
Local Institution, Taipei
Local Institution, Kaohsiung City
Local Institution, Heidelberg
Local Institution, Woolloongabba
University Of Rochester Medical Center, Rochester
Local Institution, Bologna
Cleveland Clinic, Cleveland
University Of Cincinnati Medical Center, Cincinnati
Local Institution, Valencia
Mayo Clinic, Rochester
Local Institution, Torrette Di Ancona
Local Institution, Fortaleza
Northwestern University, Chicago
University Of Nebraska Medical Center, Omaha
Tulane University Hospital & Clinic, New Orleans
Baylor University Medical Center, Dallas
Local Institution, Paris
Baylor College Of Medicine, Houston
Local Institution, Porto Alegre
Local Institution, Clichy
Local Institution, Villejuif
Local Institution, Madrid
Local Institution, Buenos Aires
Local Institution, São Paulo
Local Institution, Roma
Local Institution, Roma
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Barcelona
Local Institution, Barcelona
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY